Skip to content

Comparison of the effects of remazolam and propofol on postoperative recovery in elderly patients undergoing general anesthesia for hip surgery

Comparison of the effects of remazolam and propofol on postoperative recovery in elderly patients undergoing general anesthesia for hip surgery

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100054955
Enrollment
Unknown
Registered
2021-12-29
Start date
2022-01-01
Completion date
Unknown
Last updated
2023-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

remimazolam group:use the remimazolam as the general anesthetic in the surgery
propofol group:use the propofol as the general anesthetic in the surgery

Sponsors

The First Affiliated Hospital of Anhui Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Obtain informed consent; 2. Aged 60-90 years; 3. Patients who intend to undergo hip surgery under general anesthesia; 4. American Society of Anesthesiologists (ASA) grades I to III.

Exclusion criteria

Exclusion criteria: 1. Severe heart, lung, liver and kidney dysfunction; 2. Have a history of mental illness or long-term psychotropic drugs (dementia, schizophrenia), history of chronic analgesic drug use, history of alcoholism; 3. Patients with positive CAM before surgery; 4. Patients with preoperative Simple Mental State Questionnaire (SPMSQ) >= 8 errors, diagnosed as severe cognitive impairment; 5. Any cerebrovascular accident, such as stroke, transient ischemic attack (TIA), etc., occurred within 3 months; 6. Diabetic patients with severe diabetic complications (diabetic ketoacidosis, hyperosmolar coma, various infections, macrovascular disease, diabetic nephropathy); 7. Patients with severe infection; 8. Preoperative PaO2<60mmHg or SpO2<92%; 9. Participated in another clinical study of drugs within the past 30 days; 10. Language communication disorder, unable to complete the cognitive function test; 11. Patients with revision of prosthetic fractures; patients with hip fractures combined with severe trauma to other parts; 12. Those who are allergic to test drugs or have other contraindications to the fascia iliaca.

Design outcomes

Primary

MeasureTime frame
hip joint function;

Secondary

MeasureTime frame
activity of daily living;mortality;

Countries

China

Contacts

Public ContactLiu Xuesheng

The First Affiliated Hospital of Anhui Medical University

liuxuesheng@ahmu.edu.cn+86 18655193385

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026